Zobrazeno 1 - 10
of 796
pro vyhledávání: '"bone marrow involvement"'
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 67, Iss 1, Pp 185-188 (2024)
Juvenile xanthogranuloma is a benign self-limiting lesion commonly described in infants and young children. It most commonly involves the skin presenting as single or multiple yellowish-brown papules. Clinical scenario with the classic histomorpholog
Externí odkaz:
https://doaj.org/article/2a17a65bffb441df80aebc95560cd275
Autor:
Rutger A.J. Nievelstein, Lise Borgwardt, Thekla von Kalle, Annemieke S. Littooij, Lil-Sofie Ording Müller, Nelleke Tolboom
Publikováno v:
EJC Paediatric Oncology, Vol 4, Iss , Pp 100185- (2024)
Identifying bone marrow involvement (with or without bone destruction) in children with cancer is essential for adequate diagnosis, prognostication, therapy planning, and response assessment. Imaging plays an increasing role, with MRI including DWI a
Externí odkaz:
https://doaj.org/article/4cc8b87f6b604a1bbc247dc3eeba2404
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
ABSTRACTPurpose To explore the value of [18F]fluorodeoxyglucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in assessing bone marrow involvement (BMI) and prognosis in newly diagnosed peripheral T-cell lymphomas (PTCLs) before t
Externí odkaz:
https://doaj.org/article/6fde3aae4f0e4433bfc196ccfe2c7b05
Autor:
Keina Nozaki, Hisashi Matsushima, Hiyo Obikane, Ryohei Nishimoto, Ryo Tanaka, Takeru Morishige, Tomoko Masuda, Haruki Kume
Publikováno v:
IJU Case Reports, Vol 6, Iss 6, Pp 329-333 (2023)
Introduction Disseminated carcinomatosis of the bone marrow in prostate cancer is rare and has a poor prognosis. Although strong evidence suggests that novel hormonal agents improve the prognosis of metastatic prostate cancer, their effectiveness in
Externí odkaz:
https://doaj.org/article/7ca780e084694444b0e26f409f5c5956
Autor:
Ruah Alyamany, Riad El Fakih, Ahmed Alnughmush, Abdulwahab Albabtain, Mohamed A. Kharfan-Dabaja, Mahmoud Aljurf
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Diffuse large B cell lymphoma (DLBCL) is one of the most prevalent subtypes of non-Hodgkin lymphoma (NHL) and is known for commonly infiltrating extra-nodal sites. The involvement of the bone marrow by lymphoma cells significantly impacts the staging
Externí odkaz:
https://doaj.org/article/714c831ca0244b2a8d6c48e5f61d1a8b
Autor:
Yu Ri Kim, Ho Jin Shin, Ho-Young Yhim, Deok-Hwan Yang, Yong Park, Ji Hyun Lee, Won-Sik Lee, Young Rok Do, Yeung-Chul Mun, Dae Sik Kim, Jin Seok Kim
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundBone marrow (BM) involvement is an indicator of a poor prognosis in diffuse large B-cell lymphoma (DLBCL); however, few studies have evaluated the role of immunoglobulin gene rearrangement (IgR) in detecting BM involvement.MethodsWe evaluat
Externí odkaz:
https://doaj.org/article/45cd96a278aa4d918d0f215ef45bf304
Publikováno v:
Journal of Blood Medicine, Vol Volume 13, Pp 663-671 (2022)
ErinMarie O Kimbrough,1 Liuyan Jiang,2 Ephraim E Parent,3 Kirk Bourgeois,2 Muhamad Alhaj Moustafa,1 Han W Tun,1 Madiha Iqbal1 1Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA; 2Department of Pathology, Mayo Clinic, Jacksonvill
Externí odkaz:
https://doaj.org/article/e83ccfff79624659982d4d1b668aca12
Autor:
Tekinalp Atakan, Kars Taha Ulutan, Tuna Ali Kürşat, Kılınç İbrahim, Demircioğlu Sinan, Çeneli Özcan
Publikováno v:
Türk Biyokimya Dergisi, Vol 47, Iss 6, Pp 770-774 (2022)
We measured the serum periostin levels in patients with DLBCL and determined whether the levels reflected the clinical findings.
Externí odkaz:
https://doaj.org/article/756641fab63549c4b86d3c082bd3fd4f
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeTo investigate the diagnostic performance of integrated whole-body 18F-FDG PET/MRI for detecting bone marrow involvement (BMI) in indolent lymphoma compared with 18F-FDG PET or MRI alone.MethodsPatients with treatment-naive indolent lymphoma w
Externí odkaz:
https://doaj.org/article/560a4d70e4e549b19db391c80555ceca
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Flow cytometry (FC) is a popular method to detect bone marrow (BM) involvement in patients with B-cell non-Hodgkin lymphoma (B-NHL). The majority of screen panels of FC still rely on finding monoclonal B-cells, e.g., B-cells with
Externí odkaz:
https://doaj.org/article/adf3429948024a8a88c738d536749542